-
'Ungovernable' Britain? Once-stable politics in freefall
-
China tech giant Tencent sees Q1 profit jump after AI bets
-
Nissan expects return to profit after huge loss
-
World Cup broadcast deadlock ends up in Indian court
-
Asian stocks mixed on US-Iran impasse, AI setbacks
-
Besieged Starmer seeks to heal Labour divisions in King's Speech
-
After winter storms, fires now threaten Portugal's forests
-
Philippine senator seeks military support to block ICC drug war arrest
-
UK's Catherine on first official foreign trip since cancer revelation
-
'Short of blue-collar workers': Ukraine's battle for labour
-
'Don't understand it, but it looks fun': cricket bowls Japan over
-
Poor planning fuels Bangladesh contraceptive crisis
-
Fugitive financier sought in Malaysian fund scandal seeks Trump's pardon
-
World Cup comes to 'Soccer Town USA,' but locals priced out
-
Don't mention the war: Tucson prepares to welcome Team Iran for World Cup
-
Hosting World Cup evokes powerful memories for Mexico, and raises expectations
-
AI rivalry overshadows push for guardrails at Xi-Trump talks: experts
-
Asian stocks fall on US-Iran impasse, AI setbacks
-
Wembanyama leads Spurs to brink as Timberwolves routed
-
Ronaldo left waiting for Saudi title after goalkeeping gaffe
-
'Not my son's fault': The women bearing the children of Sudan's war rapes
-
'I applied to be pope': Losing grip on reality while using ChatGPT
-
EU to ease train travel with one journey, one ticket rules
-
Quick bowler Brown left out of Australia T20 World Cup squad
-
Los Angeles stadium undergoes World Cup facelift
-
Pacific nation Nauru to change name in break from colonial past
-
Messi still highest-paid player in MLS
-
Paramount defends Warner bid amid California probe
-
Birkenstock Reports Fiscal Second Quarter 2026 Results with Revenue Growth Of 14% In Constant FX Despite War, Tariffs and Inflation; Confirms Full-Year Target Of 13-15%
-
Greer Injury Lawyers Secures $38,816,500 Verdict for Client and Family
-
Guardian Metal Resources PLC Announces Tempiute Historical Mine Tailings Update
-
Tocvan Announces New Surface Gold-Silver Results, Outlining New Target 3 Kilometers East of Main Zone at Gran Pilar Gold-Silver Project
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 13
-
Agnete Kirk Kristiansen Appointed Chair of the LEGO Foundation
-
Blister worry hits McIlroy as PGA start looms at Aronimink
-
Tens of thousands demonstrate in Argentina over Milei university cuts
-
Ex-NBA player Jason Collins dies after brain cancer battle
-
Foot blister forces McIlroy to cut short PGA practice round
-
Man City boss Guardiola urges players to make VAR irrelevant
-
Favourites Finland, Israel through at Eurovision semis
-
Revitalized Rose sets aside Masters loss for top PGA form
-
Musk 'wanted 90%' of OpenAI, Altman tells tech titan trial
-
Former Honduras mayor arrested over murder of environmental activist
-
Conan O'Brien to host 2027 Oscars: organisers
-
Oil prices advance, stocks mostly fall on US-Iran deadlock
-
'Bittersweet' runner-up run has Scheffler inspired at PGA
-
Lakers would welcome return of LeBron James
-
Musk 'wanted 90%' of OpenAI, Altman says in high-stakes trial
-
US appeals court halts order declaring Trump's global 10% tariff illegal
-
Rubio, with new Chinese name, heads to Beijing despite sanctions
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
R.Garcia--AT